Thalidomide-4-C3-NH2 hydrochloride

Catalog No.: 
ACNGVJ464
CAS No.: 
2357110-84-8
Molecular Formula: 
C16H18ClN3O4
Molecular Weight: 
351.79
Thalidomide-4-C3-NH2 hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$403.00InquiryInquiry
100mg95%$591.00InquiryInquiry
250mg95%$839.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameThalidomide-4-C3-NH2 hydrochloride
IUPAC Name5-(3-aminopropyl)-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione hydrochloride
Molecular FormulaC16H18ClN3O4
Molecular Weight351.79
SMILESO=C1N(C(CC2)C(NC2=O)=O)C(C3=C1C=CC(CCCN)=C3)=O.[H]Cl
InChI KeyVHFJERMPPMWSPF-UHFFFAOYSA-N
Synonym1H-Isoindole-1,3(2H)-dione, 5-(3-aminopropyl)-2-(2,6-dioxo-3-piperidinyl)-, hydrochloride (1:1);Thalidomide-4-C3-NH2 hydrochloride;Thalidomide-4-C3-NH2, HCl salt;Thalidomide-4-C3-NH2 hydrochloride?, Thalidomide-4-C3-NH2 HCl
CAS No.2357110-84-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACNGVJ464 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACNGVJ464 route product structure diagram
    ACNGVJ4642357110-84-8
Inquiry

2. ACNGVJ464 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACNGVJ464 route product structure diagram
    ACNGVJ4642357110-84-8
Inquiry

3. ACNGVJ464 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACNGVJ464 route product structure diagram
    ACNGVJ4642357110-84-8
Inquiry

Comments (0)